Navigation Links
NeurogesX Reports Third Quarter 2008 Results
Date:11/6/2008

e potential utility of such partnerships in connection with NeurogesX' non-NGX-4010 development efforts; the potential markets for NeurogesX' product candidates; expected benefits of NeurogesX' product candidates; and the suitability of NGX-1998 for certain treatments and potential usage by broader physician populations. Such statements are based on management's current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to, NeurogesX' product candidates may have unexpected adverse side effects or inadequate therapeutic efficacy; positive results in clinical trials may not be sufficient to obtain FDA or European regulatory approval; any regulatory approvals which are received may be limited to certain indications; maintaining or obtaining adequate cash and other resources to carry on operations through potential regulatory approval of NGX-4010 and to carry out activities to commercialize NGX-4010, if approved; difficulties or delays in NeurogesX entering into commercialization partnerships for NGX-4010; physician or patient reluctance to use NGX-4010 or NGX-1998, if approved, or the inability of physicians to obtain sufficient reimbursement for such procedures; potential alternative therapies; maintaining adequate patent or trade secret protection without violating the intellectual property rights of others; other difficulties or delays in, clinical development, obtaining regulatory approval, market acceptance and commercialization of NeurogesX' product candidates and the advantages of NeurogesX' product candidates over other pain therapies. For further information regarding these and other risks related to NeurogesX' business, investors should consult NeurogesX' filings with the Securities and Exchange Commission.

NeurogesX, Inc.

(A Development Stage Company)

Condensed Consolidated Statements of Operations

'/>"/>
SOURCE NeurogesX, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. NeurogesX to Present at BioCenturys NewsMakers in the Biotech Industry Conference
2. NeurogesX Appoints New Director to the Board
3. NeurogesX to Present at UBS 2007 Global Life Sciences Conference
4. NeurogesX Expands Senior Management Team
5. NeurogesX to Present at CIBC World Markets 18th Annual Healthcare Conference and Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
6. NeurogesX to Present at Lazard Capital Markets Healthcare Conference
7. NeurogesX, Inc. Announces $25 Million Private Placement
8. NeurogesX Closes $25 Million Private Placement
9. NeurogesX to Present at the 10th Annual BIO CEO & Investor Conference
10. NeurogesX to Present at Roth 2008 OC Growth Stock Conference
11. NeurogesX to Report Fourth Quarter and Year-End 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 2014  Asterias Biotherapeutics, Inc. (OTCBB: ASTYV), a ... regenerative medicine, announced today that it will host ... on Tuesday, July 29, 2014, at 4:30 p.m. ... an overview of Asterias, business strategy and product ... http://www.ustream.tv/channel/asterias-biotherapeutics at least 15 minutes before the ...
(Date:7/24/2014)... sophisticated equipment, trained personnel, and detection dogs to ... attacks. A revolutionary new electronic chip with nano-sized ... much easier. , The groundbreaking nanotechnology-inspired sensor, devised ... ,s School of Chemistry and Center for Nanoscience ... Tracense, picks up the scent of explosives molecules ...
(Date:7/24/2014)... computers have yet to materialise. Yet, scientists are ... such computers faster. One such approach relies on ... by applying an electric field. A new study ... coupled quantum dots (TQDs) with electrical impulses can ... example, should TQDs be used as quantum information ...
(Date:7/24/2014)... Although most natural and synthetic processes prefer to ... potential or energyit is within the realm of ... experience constant changes in energy and phases, such ... These conditions allow humans to regulate their body ... rumble with seismic activity. , But even ...
Breaking Biology Technology:Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4Nano-sized chip 'sniffs out' explosives far better than trained dogs 2New approach to form non-equilibrium structures 2
... conversion of sunlight to electricity could brighten the ... National Laboratory (Berkeley Lab) have found a new ... place in semiconductor thin-films. This new route to ... continues to plague conventional solid-state solar cells. ...
... ... its 6th annual student award program. , ... SAN DIEGO, CA (Vocus) March 30, 2010 ... for Environmental Health & Sciences Foundation (AEHS Foundation) to recognize talented, emerging environmental ...
... genetic sleight of hand, researcher Xinyao Liu and professor ... coaxed photosynthetic microbes to secrete oilbypassing energy and cost ... appear in this week,s advanced online issue of the ... or PNAS . The challenges of ...
Cached Biology Technology:New path to solar energy via solid-state photovoltaics 2New path to solar energy via solid-state photovoltaics 3Association for Environmental Health & Sciences Foundation and Adventus Group Recognize Future Environmental Science Leaders 2Association for Environmental Health & Sciences Foundation and Adventus Group Recognize Future Environmental Science Leaders 3Association for Environmental Health & Sciences Foundation and Adventus Group Recognize Future Environmental Science Leaders 4Microbes reprogrammed to ooze oil for renewable biofuel 2Microbes reprogrammed to ooze oil for renewable biofuel 3
(Date:7/24/2014)... Neiker-Tecnalia is currently conducting research into the potato genes ... characterised by a reduction in rainfall and increased extremes ... the most resistant genes in order to create new ... conditions.The research is also seeking to find out how ... of greater drought and higher and lower temperatures. , ...
(Date:7/24/2014)... in German . ... asthma sufferers worldwide, a further 600 million people living ... global population contending with allergic rhinitis (allergic inflammation of ... other organs and parts of the body beyond the ... the form of inflammatory bowel diseases such as colitis ...
(Date:7/24/2014)... release is available in German . ... to recognize and respond to threats to health, and ... detailed understanding of the mechanism underlying immunologic memory, however, ... have converged to support the hypothesis that the persistence ... cells with stem-cell-like potential. Until now, there was no ...
Breaking Biology News(10 mins):Neiker-Tecnalia is researching the potato genes that best adapt to climate change 2New drugs to combat asthma and the like 2New drugs to combat asthma and the like 3Experiments prove 'stemness' of individual immune memory cells 2Experiments prove 'stemness' of individual immune memory cells 3
... 2012 -- Over the past 30 years, numerous studies ... such as bipolar disorder, schizophrenia, anxiety disorder and dementia. ... causes behavior disorders in a range of mammals and ... patients, but study results have been inconsistent. Now, ...
... People who have Ulcerative Colitis (UC) or Ileal ... their time between flares is crucial to successfully living ... combination of drugs, dietary changes and, for many, the ... the dietary management of these conditions. Now, Sigma-Tau Pharmaceuticals, ...
... across the globe are trying to develop plans to ... footprint by reducing the associated greenhouse gas emissions. While ... more energy efficient lighting, windows, and building systems, deeper ... a rethinking of how future infrastructure and energy policies ...
Cached Biology News:Does Borna disease virus cause mental illness? 2Maker of VSL#3 probiotic offers assistance program for ulcerative colitis and ileal pouch patients 2Columbia engineers map energy use in NYC buildings 2Columbia engineers map energy use in NYC buildings 3
... Immunogen: Immunogen corresponds to amino ... human SKAP55.,PA1-525 has been successfully used in ... By Western blot, this antibody detects an ... cells.This antibody has also been used in ...
... to suit the widest possible range of ... laboratory. Labware carriers can be placed at ... simple for the user, thanks to a ... correctly guided into position. This allows easy ...
... was developed in the late 1960s by ... the earliest commercial pioneers of immunoassay in ... in 1987. Sac-Cel rapidly found favour with ... "in house" radioimmunoassays, and became a benchmark ...
... (3-D-Gluconamidopropyl)deoxycholamide White solid. HYGROSCOPIC. A ... Has reduced electrostatic interactions that do not ... Aggregation number: 8-16. Purity: ≥95% by ... Aggregation number 8 - 16, CMC 1.1 ...
Biology Products: